Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5856290 | 1.00 | DUT (0.37) | DUT | |
| SCHEMBL17760869 | 1.00 | DUT (0.37) | DUT | |
| SCHEMBL3272116 | 1.00 | DUT (0.37) | DUT | |
| SCHEMBL345800 | 0.98 | DUT (0.38) | DUT | |
| SCHEMBL432514 | 0.91 | DUT (0.39) | DUT | |
| SCHEMBL9007756 | 0.89 | DUT (0.42) | DUT | |
| SCHEMBL27241092 | 0.89 | DUT (0.42) | DUT | |
| SCHEMBL14245094 | 0.89 | DUT (0.42) | DUT | |
| SCHEMBL8063404 | 0.86 | DUT (0.43) | DUT | |
| SCHEMBL25378318 | 0.83 | DUT (0.36) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2013-11-14 | — | — | US | disclosed |
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2013-11-14 | — | — | US | disclosed |
| US-7931946-B2 | Liquid crystal compound containing sulfone group, liquid crystal composition comprising the same, and optical film using the same liquid crystal composition | LG CHEM, LTD. (KR) | 2011-04-26 | — | — | US | disclosed |
| US-20100096590-A1 | NOVEL LIQUID CRYSTAL COMPOUND CONTAINING SULFONE GROUP, LIQUID CRYSTAL COMPOSITION COMPRISING THE SAME, AND OPTICAL FILM USING THE SAME LIQUID CRYSTAL COMPOSITION | LG CHEM, LTD. (KR) | 2010-04-22 | — | — | US | disclosed |
| US-7691836-B2 | Progesterone receptor modulators | N.V. ORGANON (NL) | 2010-04-06 | — | — | US | disclosed |
| EP-1735330-B1 | PROGESTERONE RECEPTOR MODULATORS | ORGANON NV (NL) | 2007-11-28 | — | — | EP | disclosed |
| US-20070203105-A1 | Progesterone Receptor Modulators | N.V. ORGANON (NL) | 2007-08-30 | — | — | US | disclosed |
| US-5401732-A | Autoimmune diseases | LEO PHARMACEUTICAL PRODUCTS LTD. A/S KEMISKE FABRIK PRODUKIONSAKTIESE SKAB (DK) | 1995-03-28 | — | — | US | disclosed |
| EP-0460032-B1 | NOVEL VITAMIN D ANALOGUES | LEO PHARM PROD LTD (DK) | 1994-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203105-A1 | Progesterone Receptor Modulators | PGR, PGRMC1, PGRMC2 | DUT 1885/4885 |
| US-20100096590-A1 | NOVEL LIQUID CRYSTAL COMPOUND CONTAINING SULFONE GROUP, LIQUID CRYSTAL COMPOSITION COMPRISING THE SAME, AND OPTICAL FILM USING THE SAME LIQUID CRYSTAL COMPOSITION | SFXN1, SOST, SFXN3 | DUT 4659/4885 |
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | ALOX15B, ALOX15, ALOX5 | DUT 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.